Table 1 Characteristics of the cohort
CLE, n = 13 | DM, n = 7 | Healthy controls, n = 5 | CLE uninvolved, n = 5 | |
|---|---|---|---|---|
Cases included in proteomics | 5 | 5 | 5 | 0 |
Age, M (SD) | 59 (18) | 52 (12) | 66 (21) | |
Sex, female | 13 | 5 | 3 | |
CLE/SLE | 13/10 | – | ||
DM/amyopathic DM | – | 6/1 | ||
Organ involvement at inclusion | ||||
Active rash | 13 | 7 | ||
Active arthritis | 5 | 0 | ||
Active nephritis | 2 | 0 | ||
Active CNS | 2 | 0 | ||
Active myositis | 0 | 6 | ||
Paramalignant disease | 0 | 3 | ||
Cutaneous activity indices | ||||
CLASI (available in 10) MD (IQR) | 7.5 (6–10.25) | – | ||
CDASI (available in 6), MD (IQR) | – | 18 (12.25–20.75) | ||